138 related articles for article (PubMed ID: 11219491)
1. Substantially improved in vivo radiosensitization of rat glioma with mutant HSV-TK and acyclovir.
Valerie K; Hawkins W; Farnsworth J; Schmidt-Ullrich R; Lin PS; Amir C; Feden J
Cancer Gene Ther; 2001 Jan; 8(1):3-8. PubMed ID: 11219491
[TBL] [Abstract][Full Text] [Related]
2. Improved radiosensitization of rat glioma cells with adenovirus-expressed mutant herpes simplex virus-thymidine kinase in combination with acyclovir.
Valerie K; Brust D; Farnsworth J; Amir C; Taher MM; Hershey C; Feden J
Cancer Gene Ther; 2000 Jun; 7(6):879-84. PubMed ID: 10880018
[TBL] [Abstract][Full Text] [Related]
3. Radiosensitization of human glioma cells in vitro and in vivo with acyclovir and mutant HSV-TK75 expressed from adenovirus.
Rosenberg E; Hawkins W; Holmes M; Amir C; Schmidt-Ullrich RK; Lin PS; Valerie K
Int J Radiat Oncol Biol Phys; 2002 Mar; 52(3):831-6. PubMed ID: 11849808
[TBL] [Abstract][Full Text] [Related]
4. Radiosensitization of rat glioma with bromodeoxycytidine and adenovirus expressing herpes simplex virus-thymidine kinase delivered by slow, rate-controlled positive pressure infusion.
Brust D; Feden J; Farnsworth J; Amir C; Broaddus WC; Valerie K
Cancer Gene Ther; 2000 May; 7(5):778-88. PubMed ID: 10830725
[TBL] [Abstract][Full Text] [Related]
5. [Anti-glioma activity of treatment by bone marrow stromal cells transfected with HSV-tk in the rat].
Li CH; Jiao BH
Zhonghua Zhong Liu Za Zhi; 2007 Mar; 29(3):171-5. PubMed ID: 17649630
[TBL] [Abstract][Full Text] [Related]
6. Treatment of malignant gliomas with a replicating adenoviral vector expressing herpes simplex virus-thymidine kinase.
Nanda D; Vogels R; Havenga M; Avezaat CJ; Bout A; Smitt PS
Cancer Res; 2001 Dec; 61(24):8743-50. PubMed ID: 11751394
[TBL] [Abstract][Full Text] [Related]
7. In situ generation of pseudotyped retroviral progeny by adenovirus-mediated transduction of tumor cells enhances the killing effect of HSV-tk suicide gene therapy in vitro and in vivo.
Okada T; Caplen NJ; Ramsey WJ; Onodera M; Shimazaki K; Nomoto T; Ajalli R; Wildner O; Morris J; Kume A; Hamada H; Blaese RM; Ozawa K
J Gene Med; 2004 Mar; 6(3):288-99. PubMed ID: 15026990
[TBL] [Abstract][Full Text] [Related]
8. Selective enhancement of radiation response of herpes simplex virus thymidine kinase transduced 9L gliosarcoma cells in vitro and in vivo by antiviral agents.
Kim JH; Kim SH; Kolozsvary A; Brown SL; Kim OB; Freytag SO
Int J Radiat Oncol Biol Phys; 1995 Nov; 33(4):861-8. PubMed ID: 7591895
[TBL] [Abstract][Full Text] [Related]
9. Adenovirus-mediated herpes simplex virus thymidine kinase gene therapy in BT4C rat glioma model.
Tyynelä K; Sandmair AM; Turunen M; Vanninen R; Vainio P; Kauppinen R; Johansson R; Vapalahti M; Ylä-Herttuala S
Cancer Gene Ther; 2002 Nov; 9(11):917-24. PubMed ID: 12386830
[TBL] [Abstract][Full Text] [Related]
10. Enhancement of thymidine kinase-mediated killing of malignant glioma by BimS, a BH3-only cell death activator.
Yamaguchi T; Okada T; Takeuchi K; Tonda T; Ohtaki M; Shinoda S; Masuzawa T; Ozawa K; Inaba T
Gene Ther; 2003 Mar; 10(5):375-85. PubMed ID: 12601392
[TBL] [Abstract][Full Text] [Related]
11. Preferential radiosensitization of 9L glioma cells transduced with HSV-tk gene by acyclovir.
Kim SH; Kim JH; Kolozsvary A; Brown SL; Freytag SO
J Neurooncol; 1997 Jul; 33(3):189-94. PubMed ID: 9195489
[TBL] [Abstract][Full Text] [Related]
12. HSV-tk gene therapy for human renal cell carcinoma in nude mice.
Pulkkanen KJ; Parkkinen JJ; Laukkanen JM; Kettunen MI; Tyynela K; Kauppinen RA; Ala-Opas MY; Yla-Herttuala S
Cancer Gene Ther; 2001 Jul; 8(7):529-36. PubMed ID: 11498775
[TBL] [Abstract][Full Text] [Related]
13. Recombinant interleukin-2 enhanced the antitumor effect of ADV/RSV-HSV-tk/ACV therapy in a murine bladder cancer model.
Terao S; Shirakawa T; Goda K; Kamidono S; Fujisawa M; Gotoh A
Anticancer Res; 2005; 25(4):2757-60. PubMed ID: 16080522
[TBL] [Abstract][Full Text] [Related]
14. The role of a HSV thymidine kinase stimulating substance, scopadulciol, in improving the efficacy of cancer gene therapy.
Hayashi K; Lee JB; Maitani Y; Toyooka N; Nemoto H; Hayashi T
J Gene Med; 2006 Aug; 8(8):1056-67. PubMed ID: 16779868
[TBL] [Abstract][Full Text] [Related]
15. Pronounced cytostatic activity and bystander effect of a novel series of fluorescent tricyclic acyclovir and ganciclovir derivatives in herpes simplex virus thymidine kinase gene-transduced tumor cell lines.
Balzarini J; Ostrowski T; Goslinski T; De Clercq E; Golankiewicz B
Gene Ther; 2002 Sep; 9(17):1173-82. PubMed ID: 12170381
[TBL] [Abstract][Full Text] [Related]
16. [Ganciclovir induces apoptosis of rat C6 glioma cell transduced with HSV-tk gene].
Ma W; Chen S; Ren Z; Wang W; Zhang J; Su C; Wang R; Li Y
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2000 Apr; 22(2):165-9. PubMed ID: 12903520
[TBL] [Abstract][Full Text] [Related]
17. Adenovirus-mediated gene transfer of enhanced Herpes simplex virus thymidine kinase mutants improves prodrug-mediated tumor cell killing.
Wiewrodt R; Amin K; Kiefer M; Jovanovic VP; Kapoor V; Force S; Chang M; Lanuti M; Black ME; Kaiser LR; Albelda SM
Cancer Gene Ther; 2003 May; 10(5):353-64. PubMed ID: 12719705
[TBL] [Abstract][Full Text] [Related]
18. Positron emission tomography-based imaging of transgene expression mediated by replication-conditional, oncolytic herpes simplex virus type 1 mutant vectors in vivo.
Jacobs A; Tjuvajev JG; Dubrovin M; Akhurst T; Balatoni J; Beattie B; Joshi R; Finn R; Larson SM; Herrlinger U; Pechan PA; Chiocca EA; Breakefield XO; Blasberg RG
Cancer Res; 2001 Apr; 61(7):2983-95. PubMed ID: 11306477
[TBL] [Abstract][Full Text] [Related]
19. Radiosensitization of malignant glioma cells through overexpression of dominant-negative epidermal growth factor receptor.
Lammering G; Valerie K; Lin PS; Mikkelsen RB; Contessa JN; Feden JP; Farnsworth J; Dent P; Schmidt-Ullrich RK
Clin Cancer Res; 2001 Mar; 7(3):682-90. PubMed ID: 11297265
[TBL] [Abstract][Full Text] [Related]
20. Wild Type p53 gene sensitizes rat C6 glioma cells to HSV-TK/ACV treatment in vitro and in vivo.
Huang Q; Xia Z; You Y; Pu P
Pathol Oncol Res; 2010 Dec; 16(4):509-14. PubMed ID: 20084481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
